07

Aminologics Co.Ltd

074430 · KQ · Healthcare / Pharmaceuticals

1,000.00KRW+7.00 (+0.70%)

Price History

Full chart

Market Stats

Previous Close993.00
Open981.00
Day Range981.00 – 1,010.00
52-Week Range855.00 – 1,940.00
Volume23.50K
Market Cap92.02B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.14
50-Day Avg1,090.04
200-Day Avg1,282.84

About

Aminologics Co.,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. Its products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, 4-chloro-D-phenylalanine, 3-(2-napthyl)-L-alanine, R-beta-phenylalanine, D-leucine, D-valine, 4-chloro-L-phenylalanine, D-histidine, Fmoc-D-allo-isoleucine, Fmoc-D-alanine, and Fmoc-D-phenylalanine. The company's products also comprise Boc-D-phenylalanine, L-homophenylalanine, D-homophenylalanine, 3-(3-pyridyl)-L-alanine, 3-(3-pyridyl)-D-alanine, D-cysteine HCL H2O, D-serine methyl ester HCl, Boc-D-Ser-OH, D-threonine, Fmoc-D-Leu-OH, Boc-D-4-Benzoylphenylalanine, Fmoc-D-Cyclohexylalanine, Fmoc-D-Pentafluorophenylalanine, Fmoc-D-Trp(Boc)-OH, Fmoc-L-Trp(Boc)-OH, Fmoc-D-Ser(tBu)-OH, and Fmoc-L-Ser(tBu)-OH. In addition, it operates resort and power generation businesses. Aminologics Co.,Ltd. was founded in 1997 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Hun-Yeol Hun Yun
  • Employees36
  • HeadquartersSamoh Building, Seoul, South Korea, 135-925, Korea
  • Websitehttps://www.aminologics.co.kr

Leadership

  • Mr. Hun-Yeol Hun YunChief Exec. Officer · b. 1962
  • Kyung-II KimPres · b. 1958
  • Won-Sup KimSr. Managing Director and Director of Marketing Division · b. 1959
  • Jae-Gwan LeeManaging Director · b. 1959

Financials

Income Statement

Currency: KRW2008-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue31.87B47.53B19.44B9.12B3.28B3.54B11.00B16.37B16.84B18.45B18.98B17.65B22.85B27.34B20.89B16.79B22.02B
Growth (%)-+49.15%-59.11%-53.05%-64.10%+8.10%+210.55%+48.83%+2.87%+9.59%+2.88%-7.01%+29.45%+19.64%-23.60%-19.61%+31.15%
Cost of Revenue28.92B42.87B20.10B12.30B2.98B3.42B6.42B11.96B12.95B11.37B15.69B10.66B13.71B14.53B13.11B13.37B12.16B
Gross Profit-----31.14M4.57B4.41B3.89B7.08B3.29B6.99B9.14B12.81B7.78B3.42B9.86B
Gross Margin-----0.88%41.58%26.93%23.10%38.39%17.35%39.58%39.98%46.85%37.23%20.36%44.78%
Operating Expense-----5.28B5.01B8.40B3.57B2.90B4.05B4.51B6.56B19.29B6.31B6.56B6.27B
Operating Income------5.25B-440.09M-4.00B314.50M4.18B-761.04M2.48B2.57B-6.48B1.46B-3.14B3.59B
Operating Margin------148.23%-4.00%-24.42%1.87%22.66%-4.01%14.03%11.25%-23.72%7.00%-18.70%16.32%
EBITDA--------------5.89B2.79B-555.73M4.99B
EBITDA Margin--------------21.55%13.38%-3.31%22.66%
Net Income------8.10B-2.82B-3.74B542.13M8.00B-1.20B2.14B5.36B-7.28B2.44B-1.62B3.52B
Net Income Margin------228.75%-25.69%-22.86%3.22%43.34%-6.33%12.12%23.46%-26.64%11.66%-9.65%15.99%
R&D-966.47M61.81M1.58B921.79M167.88M76.63M153.16M225.06M160.62M-339.66M474.13M215.51M1.31B112.53M139.57M
R&D as % of Total Revenue-2.03%0.32%17.28%28.14%4.74%0.70%0.94%1.34%0.87%-1.92%2.08%0.79%6.26%0.67%0.63%
Interest Expense0000000000036.32M30.92M40.01M57.08M83.42M984.46M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.21%0.14%0.15%0.27%0.50%4.47%

Balance Sheet

Currency: KRW2008-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets66.21B58.86B84.17B52.70B48.20B38.63B55.03B49.03B49.37B56.86B57.77B60.13B65.24B55.58B57.67B56.79B84.18B
Total Liabilities13.77B23.75B22.90B21.20B7.78B6.78B6.75B4.48B4.23B3.67B5.92B6.57B5.85B4.18B3.26B5.09B28.18B
Total Equity52.04B34.96B60.77B31.45B40.42B31.85B48.28B44.55B45.14B53.19B51.85B53.56B59.39B51.40B54.41B51.70B55.99B
Cash15.62B877.02M5.10B1.11B12.11B9.91B11.49B14.68B7.47B11.68B8.14B8.58B13.00K14.00K12.00B16.00K26.46B
Total Debt----------1.68B1.52B-----

Cash Flow

Currency: KRW2008-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.19B-----2.07B1.93B4.14B3.00B4.56B3.60B1.77B935.52M5.23B-218.15M7.47B2.54B
Investing Cash Flow1.08B3.59B-5.23B5.18B-130.89M2.40B-954.75M-10.20B-349.01M-6.98B-989.12M-632.38M-834.98M-155.80M-465.69M-
Financing Cash Flow--27.98B-10.55B492.00K-2.76B--141.16M-141.16M-141.16M-152.33M-164.11M-191.39M-223.92M-227.13M-
Capital Expenditure4.85B824.22M2.66B2.83B30.76M5.34M989.18M1.14B204.29M230.93M100.00M308.67M515.71M503.20M155.80M511.50M45.70M
Free Cash Flow-----------1.40B273.63M4.72B-373.95M6.95B2.49B
FCF to OCF-----------79.17%29.25%90.37%171.42%93.15%98.20%

Earnings

Report DateJun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 12, 2016Nov 11, 2016Feb 12, 2017May 12, 2017Aug 11, 2017Nov 13, 2017Jan 30, 2018May 14, 2018Aug 13, 2018Nov 13, 2018Jan 28, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Nov 13, 2022Feb 7, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------
EPS Actual-15.2685.55-276.22-16.28-295.715.11-362.29-30.66-32.64-35.07-99.41-9.70-17.04-11.56-72.28-12.13-58.985.9222.205.571.333.81-53.327.162.263.26-6.5111.0418.4710.8950.6413.153.470.01-30.31-4.9210.408.1210.779.9051.7410.95-11.5636.7310.8829.37-159.8913.112.17-6.3218.7814.695.14-17.47-20.8126.531.0215.48-2.9312.1511.27
Surprise-------------------------------------------------------------
Timing--------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours--------------After-hours---------------

Key Statistics & Ratios

Market Cap92.02B
Enterprise Value57.65B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.62
Price / Book1.61
Revenue (TTM)27.86B
Gross Profit (TTM)9.13B
EBITDA7.57B
Profit Margin20.63%
Operating Margin26.03%
Return on Equity-105.45%
Return on Assets6.76%
Shares Outstanding94.06M
Shares Float60.18M
Beta1.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20051×
18.37Dec 28, 2005
20041×
27.55Dec 29, 2004

Stock Splits

  • May 4, 2011797:732
  • Oct 23, 20095:1